Medline Inc. L10
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.86B | 7.69B | 7.35B | 7.79B | 7.12B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.86B | 7.69B | 7.35B | 7.79B | 7.12B |
| Cost of Revenue | 6.00B | 5.80B | 5.51B | 5.87B | 5.24B |
| Gross Profit | 1.86B | 1.88B | 1.84B | 1.91B | 1.88B |
| SG&A Expenses | 1.26B | 1.30B | 1.23B | 1.27B | 1.12B |
| Depreciation & Amortization | 176.00M | 177.00M | 176.00M | 176.00M | 177.00M |
| Other Operating Expenses | 10.00M | 12.00M | 15.00M | 30.00M | 8.00M |
| Total Operating Expenses | 7.45B | 7.29B | 6.93B | 7.34B | 6.54B |
| Operating Income | 410.00M | 399.00M | 422.00M | 443.00M | 574.00M |
| Income Before Tax | 386.00M | 235.00M | 291.00M | 206.00M | 345.00M |
| Income Tax Expenses | 68.00M | 96.00M | 52.00M | 26.00M | 23.00M |
| Earnings from Continuing Operations | 318.00M | 139.00M | 239.00M | 180.00M | 322.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -123.00M | -79.00M | -110.00M | 2.00M | -- |
| Net Income | 195.00M | 60.00M | 129.00M | 182.00M | 322.00M |
| EBIT | 410.00M | 399.00M | 422.00M | 443.00M | 574.00M |
| EBITDA | 669.00M | 655.00M | 676.00M | 704.00M | 827.00M |
| EPS Basic | 0.23 | 0.06 | 0.17 | 0.22 | 0.02 |
| Normalized Basic EPS | 0.07 | 0.08 | 0.09 | 0.22 | 0.01 |
| EPS Diluted | 0.22 | 0.06 | 0.16 | 0.22 | 0.02 |
| Normalized Diluted EPS | 0.05 | 0.08 | 0.09 | 0.22 | 0.01 |
| Average Basic Shares Outstanding | 876.47M | 857.00M | 819.93M | 810.00M | 17.48B |
| Average Diluted Shares Outstanding | 1.32B | 860.89M | 824.87M | 810.00M | 17.48B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 52.75% | 36.96% |